X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (58853) 58853
Book Review (12259) 12259
Newsletter (5065) 5065
Publication (4056) 4056
Newspaper Article (1718) 1718
Book Chapter (592) 592
Book / eBook (275) 275
Conference Proceeding (200) 200
Magazine Article (76) 76
Dissertation (68) 68
Trade Publication Article (47) 47
Transcript (20) 20
Web Resource (17) 17
Data Set (9) 9
Reference (8) 8
Presentation (6) 6
Report (4) 4
Government Document (3) 3
Poster (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (46735) 46735
humans (41962) 41962
male (26411) 26411
female (24478) 24478
liver (22685) 22685
transplantation (21222) 21222
middle aged (19725) 19725
surgery (17781) 17781
adult (16960) 16960
gastroenterology & hepatology (14762) 14762
liver transplantation (13642) 13642
aged (11645) 11645
treatment outcome (10010) 10010
retrospective studies (9737) 9737
mortality (9678) 9678
liver diseases (9356) 9356
risk factors (9250) 9250
prognosis (7725) 7725
animals (7456) 7456
liver cirrhosis (7298) 7298
analysis (7242) 7242
health aspects (7119) 7119
research (6980) 6980
cirrhosis (6951) 6951
liver cancer (6654) 6654
survival (6620) 6620
hepatocellular carcinoma (6097) 6097
immunology (5913) 5913
care and treatment (5857) 5857
adolescent (5760) 5760
cancer (5440) 5440
time factors (5291) 5291
abridged index medicus (5270) 5270
survival rate (5249) 5249
oncology (5225) 5225
medical research (5213) 5213
medicine & public health (5143) 5143
hepatitis (4855) 4855
liver transplantation - mortality (4796) 4796
child (4779) 4779
disease (4734) 4734
follow-up studies (4599) 4599
medicine, experimental (4521) 4521
liver neoplasms - surgery (4517) 4517
liver transplantation - adverse effects (4482) 4482
transplants & implants (4411) 4411
transplantation of organs, tissues, etc (4300) 4300
liver-transplantation (4221) 4221
patients (4095) 4095
liver neoplasms - pathology (3956) 3956
survival analysis (3931) 3931
hepatoma (3904) 3904
liver neoplasms - mortality (3824) 3824
management (3733) 3733
gastroenterology and hepatology (3596) 3596
diagnosis (3557) 3557
liver - pathology (3462) 3462
young adult (3401) 3401
hepatology (3399) 3399
carcinoma, hepatocellular - surgery (3362) 3362
hepatocellular-carcinoma (3341) 3341
liver transplantation - methods (3313) 3313
carcinoma, hepatocellular - pathology (3310) 3310
mice (3306) 3306
carcinoma, hepatocellular - mortality (3279) 3279
risk-factors (3176) 3176
recurrence (3146) 3146
child, preschool (3141) 3141
gastroenterology (3050) 3050
hepatectomy (3043) 3043
aged, 80 and over (2929) 2929
pediatrics (2902) 2902
therapy (2902) 2902
infant (2874) 2874
graft survival (2778) 2778
recipients (2752) 2752
medicine (2743) 2743
hepatitis c (2703) 2703
prospective studies (2698) 2698
children (2562) 2562
patient outcomes (2555) 2555
severity of illness index (2501) 2501
multivariate analysis (2496) 2496
infection (2493) 2493
risk (2445) 2445
liver cirrhosis - complications (2415) 2415
tumors (2400) 2400
complications (2381) 2381
living donors (2381) 2381
rats (2328) 2328
development and progression (2253) 2253
outcomes (2239) 2239
incidence (2229) 2229
medicine, general & internal (2228) 2228
experience (2195) 2195
article (2163) 2163
risk assessment (2160) 2160
fibrosis (2130) 2130
studies (2095) 2095
liver neoplasms - therapy (2084) 2084
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (206) 206
Collection Dvlpm't (Acquisitions) - Closed Orders (11) 11
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Scarborough Hospital - General (3) 3
St. Michael's Hospital - Stacks (3) 3
UofT at Mississauga - Stacks (3) 3
Humber River Regional Hospital - Church Stacks (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Baycrest Hospital - Stacks (1) 1
Church Stacks (1) 1
Credit Valley Hospital - Reference (1) 1
Credit Valley Hospital - Stacks (1) 1
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (1) 1
Gerstein Science - Reference (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
Humber River Regional Hospital - Pharmacy (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Online Resources - Online (1) 1
Providence Healthcare - Reference (1) 1
Providence Healthcare - Stacks (1) 1
Toronto East General Hospital - Online (1) 1
UofT at Mississauga - Oversize (1) 1
UofT at Mississauga - Reference (1) 1
UofT at Scarborough - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (64794) 64794
German (507) 507
Spanish (360) 360
French (290) 290
Korean (157) 157
Chinese (137) 137
Japanese (79) 79
Portuguese (63) 63
Russian (45) 45
Italian (44) 44
Hungarian (34) 34
Danish (26) 26
Polish (21) 21
Czech (18) 18
Dutch (17) 17
Swedish (17) 17
Croatian (15) 15
Romanian (15) 15
Turkish (15) 15
Hebrew (9) 9
Norwegian (7) 7
Finnish (5) 5
Icelandic (3) 3
Serbian (3) 3
Arabic (2) 2
Bulgarian (2) 2
Slovak (2) 2
Afrikaans (1) 1
Latvian (1) 1
Slovenian (1) 1
Ukrainian (1) 1
Urdu (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 11/2010, Volume 363, Issue 22, pp. 2091 - 2101
This comparison of outcomes of allogeneic hematopoietic stem-cell transplantation in 1993–1997 and 2003–2007 shows that although patients had a somewhat poorer... 
MEDICINE, GENERAL & INTERNAL | RISK-FACTORS | URSODEOXYCHOLIC ACID | BONE-MARROW-TRANSPLANTATION | IMMUNE RECONSTITUTION | COMPLICATIONS | INVASIVE FUNGAL-INFECTIONS | RECIPIENTS | CYTOMEGALOVIRUS | VERSUS-HOST-DISEASE | CONDITIONING REGIMEN | Recurrence | Graft vs Host Disease - epidemiology | Multiple Myeloma - mortality | Humans | Middle Aged | Child, Preschool | Infant | Hematopoietic Stem Cell Transplantation - mortality | Infection - etiology | Lung Diseases - etiology | Transplantation, Homologous - mortality | Young Adult | Multiple Myeloma - therapy | Myelodysplastic Syndromes - therapy | Infection - epidemiology | Graft vs Host Disease - mortality | Bone Marrow Diseases - therapy | Kidney Diseases - epidemiology | Liver Diseases - etiology | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Child | Bone Marrow Diseases - mortality | Leukemia - therapy | Mortality - trends | Liver Diseases - epidemiology | Bilirubin - blood | Lymphoma, Non-Hodgkin - therapy | Adolescent | Creatinine - blood | Aged | Lymphoma, Non-Hodgkin - mortality | Kidney Diseases - etiology | Lung Diseases - epidemiology | Leukemia - mortality | United States | Mortality | Patient outcomes | Graft versus host reaction | Transplantation | Risk factors | Hematopoietic stem cells | Cytomegalovirus | Fungal infections | Nosocomial infections | Transplants & implants | Drug dosages | Index Medicus | Abridged Index Medicus | comparative outcomes research | ursodiol | liver disease | hematopoietic cell transplantation | pulmonary disease | Marrow transplantation | survival | mortality | kidney disease | graft-vs.-host disease | infectious complications
Journal Article
Oncotarget, ISSN 1949-2553, 04/2018, Volume 9, Issue 30, pp. 21552 - 21559
Substance P is a tachykinins family member with inflammatory effects. Higher circulating levels of substance P have been found in patients with liver diseases... 
Hepatocellular carcinoma | Substance P | Mortality | Outcome | Liver transplantation
Journal Article
Heart, ISSN 1355-6037, 04/2013, Volume 99, Issue 7, pp. 491 - 496
Objective The Fontan operation is a staged palliation for complex congenital heart disease and single ventricle physiology. Perioperative survivors of the... 
LONG-TERM | CARDIAC & CARDIOVASCULAR SYSTEMS | SILDENAFIL | CIRCULATION | OPERATION | PREDICTORS | CONGENITAL HEART-DISEASE | ADULTS | CARDIORENAL SYNDROME | MODEL | LIVER-DISEASE | Heart Failure - surgery | Multivariate Analysis | Heart Defects, Congenital - surgery | Humans | Middle Aged | Heart Failure - physiopathology | Hospitals, Pediatric | Male | Death, Sudden, Cardiac - etiology | End Stage Liver Disease - blood | Fontan Procedure - adverse effects | Heart Failure - blood | Young Adult | Time Factors | Adult | Female | Retrospective Studies | Child | Heart Failure - etiology | Heart Transplantation - mortality | Boston | Heart Failure - mortality | Severity of Illness Index | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Heart Transplantation - adverse effects | Treatment Outcome | Biomarkers - blood | Fontan Procedure - mortality | Bilirubin - blood | End Stage Liver Disease - mortality | End Stage Liver Disease - etiology | Adolescent | Creatinine - blood | Heart Defects, Congenital - mortality | Hemodynamics | End Stage Liver Disease - diagnosis | Heart | Transplantation of organs, tissues, etc | Research | Health aspects | Surgery | Patient outcomes | Congenital diseases | Heart attacks | Womens health | Liver cirrhosis | Mortality | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
American Journal of Transplantation, ISSN 1600-6135, 12/2008, Volume 8, Issue 12, pp. 2537 - 2546
Journal Article
Transplantation, ISSN 0041-1337, 12/2012, Volume 94, Issue 12, pp. 1200 - 1207
Background. Donor origin cancer (DOC) in transplant recipients may be transmitted with the graft (donor-transmitted cancer [DTC]) or develop subsequently from... 
Transmitted cancer | Cancer transmission risk | Organ transplantation | Donor assessment | HOMOTRANSPLANTATION | SURGERY | LIVER RETRANSPLANTATION | ALLOGRAFT | TUMOR | DEATH | IMMUNOLOGY | RENAL-TRANSPLANT RECIPIENTS | TRANSPLANTATION | TRANSMITTED MALIGNANCY | CARCINOMA | SIROLIMUS | Carcinoma, Transitional Cell - mortality | Neoplasms - etiology | Liver Transplantation - adverse effects | Humans | Middle Aged | Male | Kidney Transplantation - statistics & numerical data | Lymphoma - mortality | Incidence | Heart Transplantation - statistics & numerical data | Carcinoma, Transitional Cell - etiology | Pancreas Transplantation - statistics & numerical data | Registries - statistics & numerical data | Kidney Neoplasms - etiology | Adult | Female | Carcinoma, Renal Cell - etiology | Heart Transplantation - mortality | Pancreas Transplantation - adverse effects | Organ Transplantation - mortality | Risk Factors | Heart Transplantation - adverse effects | Neoplasms - mortality | Liver Transplantation - mortality | Organ Transplantation - statistics & numerical data | Kidney Neoplasms - mortality | Carcinoma, Renal Cell - mortality | Liver Transplantation - statistics & numerical data | Lymphoma - etiology | Organ Transplantation - adverse effects | Survival Analysis | Tissue Donors - statistics & numerical data | Pancreas Transplantation - mortality | Kidney Transplantation - mortality | United Kingdom - epidemiology | Kidney Transplantation - adverse effects | Index Medicus | Explants | Lung cancer | Transplants | Transplantation | Radiotherapy | Lymphoma | Survival | Kidney | Risk factors | Dissolved organic carbon | Chemotherapy | Colon cancer | Databases | Donors | Neurotransmission | Kidney transplantation
Journal Article
Gastroenterology, ISSN 0016-5085, 2015, Volume 148, Issue 1, pp. 100 - 107.e1
Background & Aims Patients with detectable hepatitis C virus (HCV) RNA at the time of liver transplantation universally experience recurrent HCV infection.... 
Gastroenterology and Hepatology | Liver Transplantation | HCV Recurrence | Direct-Acting Antiviral Agents | Hepatitis C Virus | ALPHA-2A | CELLS | HEPATITIS-C INFECTION | ANTIVIRAL THERAPY | FUTURE | KINETICS | TOLERABILITY | CIRRHOSIS | GASTROENTEROLOGY & HEPATOLOGY | TREATMENT-NAIVE PATIENTS | PHASE-2 TRIAL | Recurrence | Carcinoma, Hepatocellular - mortality | Hepatitis C - drug therapy | Liver Transplantation - adverse effects | United States | Humans | Middle Aged | Liver Cirrhosis - mortality | Hepacivirus - genetics | Hepacivirus - pathogenicity | Male | RNA, Viral - blood | Liver Neoplasms - mortality | Viral Load | Time Factors | Female | Hepatitis C - complications | Waiting Lists | Uridine Monophosphate - adverse effects | Drug Therapy, Combination | Uridine Monophosphate - therapeutic use | Hepacivirus - drug effects | Liver Neoplasms - virology | Liver Cirrhosis - diagnosis | Antiviral Agents - therapeutic use | Carcinoma, Hepatocellular - diagnosis | Europe | Ribavirin - therapeutic use | Carcinoma, Hepatocellular - surgery | Genotype | Liver Neoplasms - surgery | Liver Transplantation - mortality | Treatment Outcome | Carcinoma, Hepatocellular - virology | Biomarkers - blood | New Zealand | Hepatitis C - diagnosis | Pilot Projects | Liver Cirrhosis - virology | Liver Neoplasms - diagnosis | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Hepatitis C - mortality | Uridine Monophosphate - analogs & derivatives | Liver Cirrhosis - surgery | Aged | Sofosbuvir | Medical research | Relapse | RNA | Liver | Transplantation | Biological response modifiers | Ribavirin | Infection control | Diseases | Prevention | Medicine, Experimental | Hepatitis C virus | Hepatitis C | Health aspects | Index Medicus | Abridged Index Medicus
Journal Article
Annals of Surgery, ISSN 0003-4932, 09/2012, Volume 256, Issue 3, pp. 494 - 508
Journal Article